Fund HoldingsCaligan Partners LP

Total Portfolio Value
$394.88M
Total Bought
$54.33M
Total Sold
$8.32M
Net Transaction
+$46.01M
Filing Period:
Securities
SharesValue ($K)
Q3 2024
Q4 2024
Change
Q3 2024
Q4 2024
Weight (%)
Change
LIQUIDIA CORPORATION(LQDA)8,118,5928,118,592081,186115,52829.26%+34,342
VERONA PHARMA PLC1,436,8781,436,878041,33966,72916.90%+25,390
SAGE THERAPEUTICS INC03,052,538+3,052,538016,5754.20%+16,575
EXELIXIS INC(EXEL)1,525,7301,525,730039,59350,80712.87%+11,214
MERUS N V0255,000+255,000010,7232.72%+10,723
ABIVAX SA(ABVX)0752,167+752,16705,5061.39%+5,506
VERRICA PHARMACEUTICALS INC07,429,687+7,429,68705,2011.32%+5,201
BIOCRYST PHARMACEUTICALS INC(BCRX)2,583,5852,995,932+412,34719,63522,5295.71%+2,894
MINERALYS THERAPEUTICS INC(MLYS)981,1551,011,155+30,00011,88212,4473.15%+566
OUTLOOK THERAPEUTICS INC318,6990-318,6991,7020-1,702
Y-MABS THERAPEUTICS INC1,195,2531,767,982+572,72915,71813,8433.51%-1,874
ENANTA PHARMACEUTICALS INC322,453184,826-137,6273,3411,0630.27%-2,278
I MAB3,499,3300-3,499,3304,3390-4,339
AGIOS PHARMACEUTICALS INC(AGIO)579,717626,280+46,56325,75720,5805.21%-5,177
EVOLUS INC2,193,4882,692,388+498,90035,53529,7247.53%-5,811
ANIKA THERAPEUTICS INC1,435,1301,435,130035,44823,6225.98%-11,825
Page 1 of 1